Physician profile
Matthew Lee Ramsey
NPI 1376571877
$1,680,859.39
in general payments reported to CMS, 2019-2025
14 companies · $415K in 2025
The $415K reported for 2025 was more than what 99% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $321K · 2020: $297K · 2021: $183K · 2022: $179K · 2023: $149K · 2024: $136K · 2025: $415K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $640K · Consulting Fee: $38K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $16K · Travel and Lodging: $2,782 · Food and Beverage: $2,509 · Gift: $39.49.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $640,455.61 |
| Consulting Fee | $38,110.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $15,762.50 |
| Travel and Lodging | $2,782.12 |
| Food and Beverage | $2,509.29 |
| Gift | $39.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $989,687.80 | 2021-2025 | Aetos Shoulder System, Titan, Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Integra Lifesciences Corporation | $540,053.17 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $142,615.83 | 2019-2022 | |
| Arthrex, INC. | $4,783.24 | 2021-2025 | Arthrex |
| Shoulder Innovations, INC. | $1,532.35 | 2025 | Inset System |
| Paladin Technology Solutions | $1,371.60 | 2022-2025 | |
| Ascension Orthopedics, INC. | $500.00 | 2020 | |
| Liberty Surgical INC. | $121.03 | 2021 | |
| Encore Medical, Lp | $71.92 | 2022 | |
| Stryker Corporation | $68.74 | 2023-2024 | Mako, Aequalis Perform |
| Bioventus LLC | $23.08 | 2022 | |
| Catalyst Orthoscience | $16.12 | 2020 | |
| Depuy Synthes Sales INC. | $14.51 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$22,531.49 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Ramsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.